Daymark Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.78M | Buy |
11,264
+473
| +4% | +$369K | 0.33% | 61 |
|
|
2025
Q1 | $8.91M | Buy |
10,791
+57
| +0.5% | +$47.1K | 0.38% | 56 |
|
|
2024
Q4 | $8.29M | Sell |
10,734
-986
| -8% | -$761K | 0.35% | 61 |
|
|
2024
Q3 | $10.4M | Buy |
11,720
+162
| +1% | +$144K | 0.44% | 51 |
|
|
2024
Q2 | $10.5M | Buy |
11,558
+917
| +9% | +$830K | 0.48% | 45 |
|
|
2024
Q1 | $8.28M | Sell |
10,641
-14
| -0.1% | -$10.9K | 0.45% | 53 |
|
|
2023
Q4 | $6.21M | Buy |
10,655
+173
| +2% | +$101K | 0.38% | 60 |
|
|
2023
Q3 | $5.63M | Buy |
10,482
+583
| +6% | +$313K | 0.39% | 58 |
|
|
2023
Q2 | $4.64M | Buy |
9,899
+3,965
| +67% | +$1.86M | 0.34% | 71 |
|
|
2023
Q1 | $2.04M | Buy |
5,934
+65
| +1% | +$22.3K | 0.27% | 80 |
|
|
2022
Q4 | $2.15M | Buy |
+5,869
| New | +$2.15M | 0.38% | 59 |
|